Subscribe to unlock this article
Thanks for your support.
SFs have shown a persistent and growing appetite for healthcare acquisitions over the past decade, with the trend accelerating in recent years. The appeal is not accidental: healthcare combines structural demand growth, fragmented ownership, recurring revenue models, and meaningful operational upside. Compared with more cyclical or disruption-prone sectors, healthcare businesses tend to offer a rare mix of defensibility and improvement potential.
At the core of this trend is a simple but powerful investment logic. Many healthcare businesses are essential services rather than discretionary ones. Demand is driven less by economic cycles and more by demographics, regulation, and chronic needs. As a result, revenue tends to be more stable, which in turn supports higher leverage and bank financing, a critical ingredient in SF acquisitions to maximize returns. In addition, many targets are founder-led businesses approaching succession, creating a steady pipeline of acquisition opportunities in the lower middle market.
Although healthcare is often treated as a single category, SF activity is highly concentrated in a few subsectors with favorable economics and operational dynamics:
- Healthcare services remains the largest bucket, including behavioral health, physical therapy, home care, hospice, and ABA therapy. These businesses are attractive due to recurring patient demand, fragmented local markets, and clear opportunities for multi-site scaling and operational professionalization. Behavioral health and autism services have been particularly active in recent vintages.
- Dental services is the most established playbook in PE, and we have also seen strong SF activity. Predictable visit cycles, strong cash-pay components, and highly local competition enable repeatable roll-up strategies. While not always the highest-growth segment, it remains one of the most proven for steady value creation.
- Healthcare IT / SaaS has emerged as a high-return category. Revenue cycle management, workflow tools, billing software, and compliance platforms offer sticky, subscription-based revenue with high margins and low capital intensity. These businesses tend to re-rate significantly post-acquisition due to professionalization and scalability.
- Specialty physician practice management (notably dermatology, ophthalmology, orthopedics, and gastroenterology) continues to attract capital due to procedure-driven economics, referral defensibility, and consolidation potential, particularly where there is a meaningful self-pay or ancillary revenue component.
- Outsourced healthcare services, such as billing, credentialing, staffing, and RCM, are also attractive due to recurring B2B contracts and increasing provider reliance on third-party infrastructure.
- Senior care and aging-related services benefit from long-term demographic tailwinds, especially in home-based and non-acute care models.
In 2026, several deals were completed in the healthcare sector, including Telecardio (Brazil), Odontys (France), Centrum Medyczne Primus (Poland), Super’s Diana (Spain), three medical aesthetics clinics (UK), myDiabby Healthcare (France), and Atlantic Medical Group (USA). In 2025, notable transactions included Sue’s Home Care (Australia), Pharmacom (Austria), Apoplex Medical Technologies GmbH (Germany), Alumni Home Care (USA), Crystal Practice Management (USA), PtEverywhere (USA), and Three Rivers Therapy (USA).
Not all healthcare businesses fit the SF model. Subsegments such as biotech and drug development, hospitals, and skilled nursing facilities are typically avoided due to binary regulatory risk, capital intensity, reimbursement pressure, or structurally low margins. The preference is clearly toward “healthcare-enabled services” rather than clinical or R&D-heavy businesses.
The pattern behind successful healthcare deals tends to be consistent: founder-owned businesses with strong local market positions, recurring revenue, and clear opportunities for operational improvement. These companies often sit in fragmented niches where consolidation can create significant value.
Over time, this combination has proven particularly powerful. Operational improvements drive near-term EBITDA expansion, while consolidation and scale effects often support multiple expansion at exit.
